NCT04569006 Multi-contrast Versus Multi-sequence Carotid MRI
| NCT ID | NCT04569006 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Maastricht University Medical Center |
| Condition | Atherosclerosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2021-04-08 |
| Primary Completion | 2025-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2021-04-08 with a primary completion date of 2025-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to validate 2 multi-contrast sequences, namely the Multi-contrast ATherosclerosis Characterization (MATCH) and Bright-blood and black-blOOd phase SensiTive (BOOST) inversion recovery sequence for the quantification of atherosclerotic plaque components with conventional multi-sequence MRI and histology.
Eligibility Criteria
Inclusion Criteria: In order to be eligible to participate in this study, a subject must meet the following criteria: * Patients with a carotid plaque ≥ 2 mm thick based on ultrasound or CTA * Age 18 years or older (no maximum age) * Informed consent by signing informed consent form regarding this study Exclusion Criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: * Patients with carotid plaque ≤ 2 mm in size based on ultrasound or CTA * Standard contra-indications for MRI (electronic implants like pacemakers or other electronic implants, metallic eye fragments, vascular clips, claustrophobia, etc.) * Severe co-morbidity, dementia or pregnancy
Frequently Asked Questions
Who can join the NCT04569006 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Atherosclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04569006 currently recruiting?
Yes, NCT04569006 is actively recruiting participants. Visit ClinicalTrials.gov or contact Maastricht University Medical Center to inquire about joining.
Where is the NCT04569006 trial being conducted?
This trial is being conducted at Maastricht, Netherlands.
Who is sponsoring the NCT04569006 clinical trial?
NCT04569006 is sponsored by Maastricht University Medical Center. The trial plans to enroll 40 participants.